Valvular Surgery
Your patients will benefit from our long history of internationally recognized contributions in the treatment of valvular heart disease.
These contributions include:
-
Development of the Ross procedure, of which Stanford has the largest clinical experience in Northern California
-
Site of extensive clinical trials extending over 30 years on bioprosthetic or "tissue" valves for the treatment of valvular heart disease
-
Discovery of important new knowledge concerning the pathophysiology and treatment of mitral valve disease
-
Development of an active valve-sparing aortic root replacement program that saves the patient's own aortic valve in cases of an aneurysm of the ascending aorta (applicable both for patients who have connective tissue disorders, e.g. Marfans, and those who do not)
Many of these novel discoveries can directly benefit your patients through their translation into clinical treatment for mitral valve pathology that has led to improved outcomes, particularly in the area of mitral valve repair.
The specific services available at Stanford for your patients suffering from valvular heart disease include:
-
Minimally invasive, limited incision valve repair and valve replacement
-
Autologous pulmonary valve for aortic valve replacement (Ross procedure)
-
Use of stentless aortic valves
-
Advanced mitral valve repair for mitral prolapse
-
Mitral valve repair for congestive heart failure
-
Valve-sparing aortic root replacement
-
Adjunctive procedures for atrial fibrillation